Accelerate Diagnostics, Inc. (AXDX)

0.5865 -0.0136 (-2.27%) At close: 04:00PM EDT

Accelerate Diagnostics, Inc.

3950 South Country Club Road
Suite 470 4th Floor
Tucson, AZ 85714
United States
520 365 3100
https://acceleratediagnostics.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 220

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Jack Phillips	CEO, Pres & Director	703.01k	N/A	1966
Mr. Steve Reichling	Chief Financial Officer	340k	N/A	1978
Mr. Ron Price	Chief Commercial Officer of Americas	240k	N/A	1964
Laura Pierson	Investor Relations Officer	N/A	N/A	N/A
Mr. Michael Bridge	Sr. VP, Gen. Counsel & Sec.	N/A	N/A	N/A
Ms. Gretchen Strohminger	Sr. VP and Head of HR & Culture	N/A	N/A	N/A
Mr. Cherif Bousselham	Sr. VP & Head of Sales - EMEA	N/A	N/A	N/A
Ms. Laura Costa	Sr. VP & Head of Global Customer Support	N/A	N/A	N/A
Mr. John Meduri	Chief Strategy Officer	N/A	N/A	N/A
Dr. Lawrence Mertz	Sr. VP and Head of R&D	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

Corporate Governance

Accelerate Diagnostics, Inc.’s ISS Governance QualityScore as of May 1, 2022 is 7. The pillar scores are Audit: 7; Board: 6; Shareholder Rights: 2; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.